Incidence and Mortality of Thyroid Cancer in Hefei City,Anhui Province in 2021 and the Trend from 2013 to 2021
10.11735/j.issn.1004-0242.2025.03.A004
- VernacularTitle:2021年安徽省合肥市甲状腺癌流行特征及2013-2021年变化趋势分析
- Author:
Jiajia LI
1
;
Xiaopeng ZHANG
1
;
Junqing ZHANG
1
;
Feng SUN
1
;
Xiaoru LI
1
Author Information
1. 合肥市疾病预防控制中心,安徽 合肥 230091
- Publication Type:Journal Article
- Keywords:
thyroid cancer;
incidence;
mortality;
trend;
Anhui
- From:
China Cancer
2025;34(3):188-194
- CountryChina
- Language:Chinese
-
Abstract:
[Purpose]To analyze the incidence and mortality of thyroid cancer in Hefei of Anhui Province in 2021 and the trend from 2013 to 2021.[Methods]Using the data of Hefei Cancer Registry,the crude incidence/mortality rate,age-standardized incidence/mortality rate by Chinese standard population(ASIRC/ASMRC)and world standard population(ASIRW/ASMRW)were cal-culated in 2021.The average annual percentage change(AAPC)of the crude incidence/mortality rate and age-standardized incidence/mortality rate were calculated using Joinpoint software to ana-lyze trends from 2013 to 2021.[Results]In 2021,the crude incidence rate of thyroid cancer in Hefei was 47.54/105,the ASIRC was 42.30/105,the ASIRW was 35.85/105.The crude mortality rate of thyroid cancer was 0.70/105,the ASMRC was 0.38/105,the ASMRW was 0.40/105.The in-cidence rate of thyroid cancer reached its peak in the 50～54 age group and the mortality rate reached its peak in the group over 85 years old.The incidence rate and mortality rate of women were higher than those of men,and the incidence and mortality rates in urban areas were higher than those in rural areas.The incidence and mortality of thyroid cancer showed a upward trend from 2013 to 2021 in Hefei City(AAPC were 38.23％and 9.68％,both P＜0.05).[Conclusion]The ASIRC/ASMRC of thyroid cancer showed a upward trend from 2013 to 2021 in Hefei City.It is necessary to strengthen prevention and control to reduce the exposure of risk factors.At the same time,diagnosis and treatment should be standardized to avoid over diagnosis.
